146 related articles for article (PubMed ID: 37355392)
21. Analysis of patients scheduled for neoadjuvant therapy followed by surgery for esophageal cancer, who never made it to esophagectomy.
Depypere L; Thomas M; Moons J; Coosemans W; Lerut T; Prenen H; Haustermans K; Van Veer H; Nafteux P
World J Surg Oncol; 2019 May; 17(1):89. PubMed ID: 31133018
[TBL] [Abstract][Full Text] [Related]
22. How does presurgical chemotherapy influence the efficiency of treatment for esophageal cancer recurrence after curative esophagectomy?
Taniyama Y; Sakurai T; Hikage M; Okamoto H; Sato C; Takaya K; Unno M; Kamei T
Thorac Cancer; 2019 Apr; 10(4):769-774. PubMed ID: 30756477
[TBL] [Abstract][Full Text] [Related]
23. Multi-institutional Analysis of Recurrence and Survival After Neoadjuvant Chemoradiotherapy of Esophageal Cancer: Impact of Histology on Recurrence Patterns and Outcomes.
Xi M; Yang Y; Zhang L; Yang H; Merrell KW; Hallemeier CL; Shen RK; Haddock MG; Hofstetter WL; Maru DM; Ho L; Wu CC; Liu M; Lin SH
Ann Surg; 2019 Apr; 269(4):663-670. PubMed ID: 29334555
[TBL] [Abstract][Full Text] [Related]
24. Chemoradiotherapy versus chemoradiotherapy plus surgery for esophageal cancer.
Vellayappan BA; Soon YY; Ku GY; Leong CN; Lu JJ; Tey JC
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD010511. PubMed ID: 28829911
[TBL] [Abstract][Full Text] [Related]
25. Patterns and Outcomes of Recurrent Esophageal Cancer After Curative Esophagectomy.
Yamashita K; Watanabe M; Mine S; Kurogochi T; Okamura A; Hayami M; Imamura Y
World J Surg; 2017 Sep; 41(9):2337-2344. PubMed ID: 28432391
[TBL] [Abstract][Full Text] [Related]
26. A meta-analysis on salvage surgery as a potentially curative procedure in patients with isolated local recurrent or persistent esophageal cancer after chemoradiotherapy.
Faiz Z; Dijksterhuis WPM; Burgerhof JGM; Muijs CT; Mul VEM; Wijnhoven BPL; Smit JK; Plukker JTM
Eur J Surg Oncol; 2019 Jun; 45(6):931-940. PubMed ID: 30447937
[TBL] [Abstract][Full Text] [Related]
27. Outcomes With Open and Minimally Invasive Ivor Lewis Esophagectomy After Neoadjuvant Therapy.
Tapias LF; Mathisen DJ; Wright CD; Wain JC; Gaissert HA; Muniappan A; Lanuti M; Donahue DM; Morse CR
Ann Thorac Surg; 2016 Mar; 101(3):1097-103. PubMed ID: 26652140
[TBL] [Abstract][Full Text] [Related]
28. Recurrent Disease After Esophageal Cancer Surgery: A Substudy of The Dutch Nationwide Ivory Study.
Kalff MC; Henckens SPG; Voeten DM; Heineman DJ; Hulshof MCCM; van Laarhoven HWM; Eshuis WJ; Baas PC; Bahadoer RR; Belt EJT; Brattinga B; Claassen L; Ćosović A; Crull D; Daams F; van Dalsen AD; Dekker JWT; van Det MJ; Drost M; van Duijvendijk P; van Esser S; Gaspersz MP; Görgec B; Groenendijk RPR; Hartgrink HH; van der Harst E; Haveman JW; Heisterkamp J; van Hillegersberg R; Kelder W; Kingma BF; Koemans WJ; Kouwenhoven EA; Lagarde SM; Lecot F; van der Linden PP; Luyer MDP; Nieuwenhuijzen GAP; Olthof PB; van der Peet DL; Pierie JEN; Pierik EGJMR; Plat VD; Polat F; Rosman C; Ruurda JP; van Sandick JW; Scheer R; Slootmans CAM; Sosef MN; Sosef OV; de Steur WO; Stockmann HBAC; Stoop FJ; Vugts G; Vijgen GHEJ; Weeda VB; Wiezer MJ; van Oijen MGH; van Berge Henegouwen MI; Gisbertz SS
Ann Surg; 2022 Nov; 276(5):806-813. PubMed ID: 35880759
[TBL] [Abstract][Full Text] [Related]
29. Neoadjuvant versus definitive chemoradiotherapy for locally advanced esophageal cancer : Outcomes and patterns of failure.
Haefner MF; Lang K; Verma V; Koerber SA; Uhlmann L; Debus J; Sterzing F
Strahlenther Onkol; 2018 Feb; 194(2):116-124. PubMed ID: 28916906
[TBL] [Abstract][Full Text] [Related]
30. Elective nodal irradiation is not necessary in chemoradiotherapy for postoperative loco-regional recurrent esophageal cancer.
Jingu K; Umezawa R; Yamamoto T; Matsushita H; Ishikawa Y; Kozumi M; Kubozono M; Takahashi N; Kadoya N; Takeda K
Jpn J Clin Oncol; 2017 Mar; 47(3):200-205. PubMed ID: 28031356
[TBL] [Abstract][Full Text] [Related]
31. Long-term results of radiotherapy combined with nedaplatin and 5-fluorouracil for postoperative loco-regional recurrent esophageal cancer: update on a phase II study.
Jingu K; Matsushita H; Takeda K; Umezawa R; Takahashi C; Sugawara T; Kubozono M; Abe K; Tanabe T; Shirata Y; Yamamoto T; Ishikawa Y; Nemoto K
BMC Cancer; 2012 Nov; 12():542. PubMed ID: 23171077
[TBL] [Abstract][Full Text] [Related]
32. Long-term Efficacy of Neoadjuvant Chemoradiotherapy Plus Surgery for the Treatment of Locally Advanced Esophageal Squamous Cell Carcinoma: The NEOCRTEC5010 Randomized Clinical Trial.
Yang H; Liu H; Chen Y; Zhu C; Fang W; Yu Z; Mao W; Xiang J; Han Y; Chen Z; Yang H; Wang J; Pang Q; Zheng X; Yang H; Li T; Zhang X; Li Q; Wang G; Chen B; Mao T; Kong M; Guo X; Lin T; Liu M; Fu J
JAMA Surg; 2021 Aug; 156(8):721-729. PubMed ID: 34160577
[TBL] [Abstract][Full Text] [Related]
33. CMISG1701: a multicenter prospective randomized phase III clinical trial comparing neoadjuvant chemoradiotherapy to neoadjuvant chemotherapy followed by minimally invasive esophagectomy in patients with locally advanced resectable esophageal squamous cell carcinoma (cT
Tang H; Tan L; Shen Y; Wang H; Lin M; Feng M; Xu S; Guo W; Qian C; Liu T; Zeng Z; Hou Y; Yu Z; Jiang H; Li Z; Chen C; Lian C; Du M; Li H; Xie D; Yin J; Zhao N; Wang Q
BMC Cancer; 2017 Jun; 17(1):450. PubMed ID: 28659128
[TBL] [Abstract][Full Text] [Related]
34. Definitive chemoradiation for locoregional recurrences of esophageal cancer after primary curative treatment.
Jeene PM; Versteijne E; van Berge Henegouwen MI; Bergmann JJ; Geijsen ED; Muller K; van Laarhoven HW; Hulshof MC
Dis Esophagus; 2017 Feb; 30(2):1-5. PubMed ID: 27766725
[TBL] [Abstract][Full Text] [Related]
35. Pattern of recurrence in patients with a pathologically complete response after neoadjuvant chemoradiotherapy and surgery for oesophageal cancer.
de Jongh M; Eyck BM; van der Werf LR; Toxopeus ELA; van Lanschot JJB; Lagarde SM; van der Gaast A; Nuyttens J; Wijnhoven BPL
BJS Open; 2021 Mar; 5(2):. PubMed ID: 33876211
[TBL] [Abstract][Full Text] [Related]
36. Distribution of Residual Disease and Recurrence Patterns in Pathological Responders After Neoadjuvant Chemotherapy for Esophageal Squamous Cell Carcinoma.
Matsuda S; Kawakubo H; Okamura A; Takahashi K; Toihata T; Takemura R; Mayanagi S; Hirata K; Irino T; Hamamoto Y; Takeuchi H; Watanabe M; Kitagawa Y
Ann Surg; 2022 Aug; 276(2):298-304. PubMed ID: 33074909
[TBL] [Abstract][Full Text] [Related]
37. Analysis of prognostic factors in patients with lymph node recurrence after radical esophagectomy: importance of locoregional therapy.
Tanaka K; Yamasaki M; Makino T; Yamashita K; Saitoh T; Takahashi T; Kurokawa Y; Nakajima K; Motoori M; Kimura Y; Mano M; Mori M; Eguchi H; Doki Y
Esophagus; 2021 Apr; 18(2):195-202. PubMed ID: 32875459
[TBL] [Abstract][Full Text] [Related]
38. Risk factors of early recurrence within 6 months after esophagectomy following neoadjuvant chemotherapy for resectable advanced esophageal squamous cell carcinoma.
Yoshida N; Baba Y; Shigaki H; Harada K; Iwatsuki M; Sakamoto Y; Miyamoto Y; Kurashige J; Kosumi K; Tokunaga R; Watanabe M; Baba H
Int J Clin Oncol; 2016 Dec; 21(6):1071-1078. PubMed ID: 27255393
[TBL] [Abstract][Full Text] [Related]
39. Recurrence dynamics after trimodality therapy (Neoadjuvant concurrent chemoradiotherapy and surgery) in patients with stage IIIA (N2) lung cancer.
Lee J; Kim HK; Park BJ; Cho JH; Choi YS; Zo JI; Shim YM; Pyo H; Ahn YC; Ahn JS; Ahn MJ; Park K; Kim J
Lung Cancer; 2018 Jan; 115():89-96. PubMed ID: 29290268
[TBL] [Abstract][Full Text] [Related]
40. Total FDG lesion number on PET/CT predicts survival of esophageal carcinoma patients with recurrence following curative surgery.
Kim SJ; Hyun SH; Moon SH; Cho YS; Yi HK; Shim YM; Choi JY; Kim BT; Lee KH
Q J Nucl Med Mol Imaging; 2020 Jun; 64(2):211-218. PubMed ID: 29697218
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
